Clinical trials, Yellow cards, Chemo brain, C...

We’ve had two heatwaves already this summer with warnings that even young and healthy people should rethink their fitness routines in the heat. So how can we keep exercising when it’s so hot you barely want to move? James chats with physiologist Damian Bailey from the University ...  Show more

Earlier this summer, there was some incredible progress in cervical cancer. Women who have been vaccinated against the human papillomavirus (HPV) now have an almost zero chance of dying from cervical cancer before the age of 30. But does that mean women will no longer need cervic ...  Show more

Why does one child become rebellious and another not? Claudia Hammond talks to Mark McDermott from the University of East London about new research into parenting and rebelliousness. She also hears from another shortlisted entry to the All in the Mind mental health awards. Plus, ...  Show more

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...

A new medication for psychosis is on the horizon. It's called KarXT and it could mean fewer side effects as well as finally some relief from difficulties with attention, concentration and memory - these are the symptoms patients often report as having the greatest impact on their ...  Show more

Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.

Hosted b ...